FBXW7 and DNA copy number instability

被引:0
|
作者
Kristin N. Byrd
Bing Huey
Ritu Roydasgupta
Jane Fridlyand
Antoine M. Snijders
Donna G. Albertson
机构
[1] University of California San Francisco,Cancer Research Institute
[2] University of California San Francisco,Comprehensive Cancer Center
[3] University of California San Francisco,Department of Laboratory Medicine
[4] University of California San Francisco,Department of Epidemiology and Biostatistics
来源
关键词
Genome instability; Array CGH;
D O I
暂无
中图分类号
学科分类号
摘要
SKP1-cullin-F-box protein (SCF) type ubiquitin ligases degrade proteins controlling the G1/S transition. Deficiency for FBXW7 (also known as hCDC4), which encodes the F-box protein of the SCF type ubiquitin ligase is associated with genomic instability. Here, we investigated the association of FBXW7 deficiency with chromosomal instability in breast cancer. We screened 49 tumors previously profiled by array CGH for mutations in conserved regions of FBXW7, but found no mutations. Copy number loss of FBXW7, however was associated with enhanced genomic instability in the Complex breast tumor subtype, but instability may not be due to FBXW7 haploinsufficiency, since transcript levels were not reduced in tumors with loss of the locus, whereas reduced expression was observed for other neighboring genes involved in maintenance of genome stability. We also investigated whether cells deficient for FBXW7 showed enhanced instability by challenging cells with methotrexate and assessing numbers of genomic alterations arising in resistant cells. Although methotrexate resistant colonies formed at high frequencies in HCT116 FBXW7+/− and HCT116 FBXW7−/− cells compared to parental HCT116, few copy number alterations were detected in the resistant cells. Taken together these studies suggest that FBXW7 deficiency is unlikely to contribute to the extensive copy number aberrations associated with breast and possibly other tumor types.
引用
收藏
页码:47 / 54
页数:7
相关论文
共 50 条
  • [41] Loss of CDC4/FBXW7 in gastric carinoma
    Milne, A. N.
    Leguit, R.
    Corver, W. E.
    Morsink, F. H. M.
    Polak, M.
    de Leng, W. W.
    Carvalho, R.
    Offerhaus, G. J. A.
    CELLULAR ONCOLOGY, 2010, 32 (5-6) : 347 - 359
  • [42] Calpain-mediated cleavage of Fbxw7 during excitotoxicity
    Ko, Yeon Uk
    Song, Hwa Young
    Kim, Won-Ki
    Yune, Tae Young
    Yun, Nuri
    Oh, Young J.
    NEUROSCIENCE LETTERS, 2020, 736
  • [43] Emerging roles for the FBXW7 ubiquitin ligase in leukemia and beyond
    Kourtis, Nikos
    Strikoudis, Alexandros
    Aifantis, Iannis
    CURRENT OPINION IN CELL BIOLOGY, 2015, 37 : 28 - 34
  • [44] Differential regulation of FBXW7 isoforms by various stress stimuli
    Sionov, Ronit Vogt
    Netzer, Efrat
    Shaulian, Eitan
    CELL CYCLE, 2013, 12 (22) : 3547 - 3554
  • [45] Mutation in the FBXW7 Tumor Suppressor Gene of a childlike Melanoma
    Pfoehler, C.
    Ugurel, S.
    Sucker, A.
    Krecke, N.
    Becker, S.
    Vogt, T.
    Mueller, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 21 - 21
  • [46] FBXW7 and the Hallmarks of Cancer: Underlying Mechanisms and Prospective Strategies
    Shen, Wenyue
    Zhou, Quanwei
    Peng, Chenxi
    Li, Jiaheng
    Yuan, Qizhi
    Zhu, Hecheng
    Zhao, Ming
    Jiang, Xingjun
    Liu, Weidong
    Ren, Caiping
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [47] Fbxw7 triggers degradation of WDR7 to prevent mitotic slippage
    Haenle-Kreidler, S.
    Richter, K. T.
    Hoffmann, I.
    MOLECULAR BIOLOGY OF THE CELL, 2023, 34 (02) : 165 - 165
  • [48] Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy
    Xing, Liangliang
    Xu, Leidi
    Zhang, Yong
    Che, Yinggang
    Wang, Min
    Shao, Yongxiang
    Qiu, Dan
    Yu, Honglian
    Zhao, Feng
    Zhang, Jian
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [49] Clinical significance of FBXW7 loss of function in human cancers
    Fan, Jingyi
    Bellon, Marcia
    Ju, Mingyi
    Zhao, Lin
    Wei, Minjie
    Fu, Liwu
    Nicot, Christophe
    MOLECULAR CANCER, 2022, 21 (01)
  • [50] FBXW7 in breast cancer: mechanism of action and therapeutic potential
    Siyu Chen
    Ping Leng
    Jinlin Guo
    Hao Zhou
    Journal of Experimental & Clinical Cancer Research, 42